Subcutaneously injected glucagon-like peptide-1 (GLP-1) analogues improve glucose metabolism and ... and 15 min to test total GLP-1 and insulin plasma concentration by using ELISA kits (Meso Scale ...

ELISA kits (JL21292), rat glucagon-like peptide 1 (GLP1) ELISA kits (JL12394), rat high density lipoprotein (HDL) ELISA kit (JL13845), rat low density lipoprotein (LDL) ELISA kit (JL13846), and rat ...

Immunolabelling showed specific colocalisation of receptors with EEC mediators PYY and GLP-1 (L-cells) or 5-HT (enterochromaffin ... before being placed into the Ussing chamber. Where hormone/peptide ...

Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among experts, a new study says.

The following is a summary of “Optimizing SGLT2 inhibitor and GLP-1 RA prescribing in high-risk patients with diabetes: a ...

Weight loss is a key effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), but these drugs may also provide liver ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

There’s no denying that GLP-1 medications like Ozempic and Wegovy are having a moment. You’ve probably seen the headlines, ...

Initial reports of increased suicidality in GLP-1 RA users compared with the general population raised concerns about the risk for this rare but serious adverse event, given the rising popularity ...

Findings from the American College of Cardiology 2025 Annual Scientific Session show oral semaglutide reduces the risk of heart attack, stroke, and cardiovascular death by 14% in patients with type 2 ...

Learn how chemists have invented a new technology to solve the shortage of GLP-1 medications by improving drug delivery.